UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 826

Sortiert nach

The Yin-Yang of Tumor-Associated Neutrophils

Cancer cell, 2009-09, Vol.16 (3), p.173-174

Mantovani, Alberto

2009

Link zum Volltext

Verfügbarkeit prüfen

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Cell reports (Cambridge), 2022-05, Vol.39 (7), p.110814-110814, Article 110814

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

Nature (London), 2016-03, Vol.531 (7592), p.110-113

2016

Link zum Volltext

Verfügbarkeit prüfen

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Nature (London), 2016-06, Vol.534 (7605), p.129-132

2016

Link zum Volltext

Verfügbarkeit prüfen

Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

Cancer cell, 2011-06, Vol.19 (6), p.754-764

2011

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy

ACS nano, 2020-02, Vol.14 (2), p.1468-1481

2020

Link zum Volltext

Verfügbarkeit prüfen

Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma

Nature communications, 2023-03, Vol.14 (1), p.1794-1794, Article 1794

2023

Link zum Volltext

Verfügbarkeit prüfen

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling

The Journal of clinical investigation, 2023-01, Vol.133 (1), p.1-19

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the cell of origin for small cell lung cancer

Cell cycle (Georgetown, Tex.), 2011-08, Vol.10 (16), p.2806-2815

2011

Link zum Volltext

Verfügbarkeit prüfen

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

PloS one, 2014-09, Vol.9 (9), p.e106914-e106914

2014

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

EMBO molecular medicine, 2018-03, Vol.10 (3), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane

Biochemical and biophysical research communications, 2021-01, Vol.534, p.172-178

2021

Link zum Volltext

Verfügbarkeit prüfen

AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

Cell death & disease, 2019-05, Vol.10 (5), p.361-361, Article 361

2019

Link zum Volltext

Verfügbarkeit prüfen

NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer

Cell death & disease, 2022-10, Vol.13 (10), p.891-891, Article 891

2022

Link zum Volltext

Verfügbarkeit prüfen

EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer

Cancer letters, 2015-04, Vol.359 (2), p.275-287

2015

Link zum Volltext

Verfügbarkeit prüfen

Validation of an orthotopic non-small cell lung cancer mouse model, with left or right tumor growths, to use in conformal radiotherapy studies

PloS one, 2023-04, Vol.18 (4), p.e0284282-e0284282

2023

Link zum Volltext

Verfügbarkeit prüfen

Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway

Cell cycle (Georgetown, Tex.), 2022-01, Vol.21 (1), p.86-100

2022

Link zum Volltext

Verfügbarkeit prüfen

Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo

Scientific reports, 2024-01, Vol.14 (1), p.2348-2348, Article 2348

2024

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3

Scientific reports, 2016-03, Vol.6, p.23100-23100

2016

Link zum Volltext

Verfügbarkeit prüfen

Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer

Oncogene, 2020-01, Vol.39 (5), p.1152-1164

2020

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway

Journal of cellular and molecular medicine, 2023-11, Vol.27 (22), p.3526-3538

2023

Link zum Volltext

Verfügbarkeit prüfen

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

Biomaterials, 2014-07, Vol.35 (23), p.6118-6129

2014

Link zum Volltext

Verfügbarkeit prüfen

PD-1 Blockade in Early-Stage Lung Cancer

Annual review of medicine, 2019-01, Vol.70, p.425

2019

Link zum Volltext

Verfügbarkeit prüfen

LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells

Biochemical and biophysical research communications, 2020-07, Vol.528 (2), p.330-335

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 826

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(745)
Mit Volltextzugriff
(769)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(708)
Life Sciences & Biomedicine
(649)
Lung Cancer
(470)
Pathology
(408)
Non-Small Cell Lung Carcinoma
(373)
Animals
(333)
Tumors
(301)
Lung Neoplasms - Pathology
(295)
Oncology
(293)
Mice
(263)
Small Cell Lung Carcinoma
(249)
Carcinoma, Non-Small-Cell Lung - Pathology
(211)
Patients
(173)
Mutation
(167)
Cancer
(164)
Metastasis
(160)
Cancer Therapies
(149)
Chemotherapy
(136)
Cell Line, Tumor
(125)
Non-Small Cell Lung Cancer
(123)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The Yin-Yang of Tumor-Associated Neutrophils

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy

Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling

Characterization of the cell of origin for small cell lung cancer

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer

CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane

AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer

EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer

Validation of an orthotopic non-small cell lung cancer mouse model, with left or right tumor growths, to use in conformal radiotherapy studies

Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway

Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo

Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3

Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer

Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

PD-1 Blockade in Early-Stage Lung Cancer

LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells

Aktive Filter

Suchergebnisse filtern